The vancomycin family of natural products have become increasingly important therapeutic agents in the treatment of Gram-positive bacterial infections caused by methicillin resistant Staphylococcus aureus and bacterial infections. In light of the recent emergence of vancomycin resistance in the clinic as well as the remarkable biological activity of the vancomycin family of antibiotics, the structural complexity, and the interest in elucidating the structure-biological activity relationships (SAR), the development of a practical synthetic approach to vancomycin is a highly desirable objective. The primary target is to discover novel general synthetic methods, in conjunction with reliable known protocols, to form the highly strained biaryl 12-membered AB ring in vancomycin, the most challenging aspect of any projected synthesis of this family of natural products. An additional goal is to elucidate the most efficient order for the installation of the AB, CD, and DE rings via biaryl and diphenyl ether linkages in vancomycin, an important and unexplored area. The ultimate aim is to accomplish the first total synthesis of the vancomycin aglycone in a convergent fashion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI009847-01A1
Application #
2708831
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1999-03-19
Project End
Budget Start
1998-09-30
Budget End
1999-05-03
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037